Immunohistochemical analysis showed that IL-6, IL-6R and gp130 are highly expressed in tumor sections of the control NOD/SCID mice, while in sgp130-treated mice, their expression levels are significantly lower (Fig. 5b). This evidence concerns the gene IL6ST and neoplasm.